Newsbenzinga
What'sGoing On With AbCellera Biologics Stock On Tuesday?
· Published
Article summary
AbCellera Biologics stock gains as investors react to Jazz Pharmaceuticals’ FDA approval and the companies’ antibody partnership.
An excerpt from the original article.
Comments —
Loading comments…